Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-020248

Chief Financial Officer sold 1,000 shares at $194.35 ($194,350)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-07-08 Sale : show line 1 in the form 10b5-1 −1,000 $194.35 $194,350 90,056 D
Open-market sales · 1,000 sh · avg $194.35 · $194,350
Loading xslF345X05/form4.xml…